PMC:3220857 / 1755-2134
Annnotations
{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/3220857","sourcedb":"PMC","sourceid":"3220857","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3220857","text":"Patients with type 2 diabetes mellitus display a typical atherogenic dyslipidemia marked by increased plasma triglycerides (TG) and VLDL-cholesterol concentrations and decreased HDL-cholesterol levels. Furthermore, hepatic steatosis, which is also strongly associated with cardiovascular disease risk (1,2), is frequently observed in patients with type 2 diabetes mellitus (3–5).","tracks":[]}